Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 2,781 | 2,961 | 725 | 0 | 0 |
| Cost of Goods | 783 | 485 | 269 | N/A | N/A |
| Gross Profit | 1,998 | 2,476 | 456 | N/A | N/A |
| Operating Expenses | 79,046 | 71,385 | 105,473 | 65,827 | 62,628 |
| Operating Income | -76,265 | -68,424 | -104,748 | -65,827 | -62,628 |
| Interest Expense | 7,042 | 6,915 | 4,899 | 2,000 | 1,838 |
| Other Income | 3,207 | 3,320 | 1,938 | 421 | 142 |
| Pre-tax Income | -80,100 | -72,019 | -107,709 | -67,406 | -64,324 |
| Net Income Continuous | -80,100 | -72,019 | -107,709 | -67,406 | -64,324 |
| Net Income | $-80,100 | $-72,019 | $-107,709 | $-67,406 | $-64,324 |
| EPS Basic Total Ops | -1.31 | -1.19 | -1.89 | -1.31 | -1.27 |
| EPS Basic Continuous Ops | -1.31 | -1.19 | -1.89 | -1.31 | -1.27 |
| EPS Diluted Total Ops | -1.31 | -1.19 | -1.89 | -1.31 | -1.27 |
| EPS Diluted Continuous Ops | -1.31 | -1.19 | -1.89 | -1.31 | -1.27 |
| EPS Diluted Before Non-Recurring Items | -1.31 | -1.18 | -1.89 | N/A | N/A |
| EBITDA(a) | $-78,063 | $-70,419 | $-105,267 | $-65,400 | $-61,860 |